Co-Authors
This is a "connection" page, showing publications co-authored by Vincent Munster and Atsushi Okumura.
Connection Strength
1.807
-
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models. Sci Transl Med. 2021 08 18; 13(607).
Score: 0.240
-
Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature. 2021 Feb; 590(7844):E24.
Score: 0.232
-
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature. 2020 10; 586(7830):578-582.
Score: 0.224
-
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques. Sci Adv. 2020 06; 6(24):eaba8399.
Score: 0.222
-
Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 2020 09; 585(7824):268-272.
Score: 0.220
-
Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets. Antiviral Res. 2017 07; 143:30-37.
Score: 0.178
-
Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog. 2014 Aug; 10(8):e1004250.
Score: 0.148
-
Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A. 2013 Oct 08; 110(41):16598-603.
Score: 0.139
-
Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys. Sci Transl Med. 2021 01 27; 13(578).
Score: 0.058
-
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection. Emerg Microbes Infect. 2020 Dec; 9(1):2673-2684.
Score: 0.057
-
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature. 2020 09; 585(7824):273-276.
Score: 0.055
-
Treatment with interferon-a2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med. 2013 Oct; 19(10):1313-7.
Score: 0.035